Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannan

Josephine Anne D Navoa, Suman Laal, Liise-anne Pirofski, Gary R. McLean, Zhongdong Dai, John B. Robbins, Rachel Schneerson, Arturo Casadevall, Aharona Glatman-Freedman

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Arabinomannan (AM) is a polysaccharide antigen of the mycobacterial capsule. However, it is uncertain whether AM constitutes an immunologically distinct fraction of Mycobacterium tuberculosis. In this study, we analyzed the repertoire and specificity of antibodies to AM by using AM-binding murine monoclonal antibodies (MAbs) and human serum samples. Murine MAbs were found to be diverse in their specificity to AM and cross-reactivity with other arabinose-containing mycobacterial polysaccharides, with MAb 9d8 binding exclusively to AM. Human antibodies to AM were detected in serum samples from patients with pulmonary tuberculosis (TB), as well as in those from healthy, purified protein derivative-negative controls, with significantly higher titers among patients. The binding of human antibodies to AM was inhibited by MAb 9d8 in three patients with TB but not in controls. MAb 5c11, which recognizes other mycobacterial arabinose-containing carbohydrates in addition to AM, inhibited the binding of serum samples from 75% of patients and 76% of controls. Analysis of human antibodies with murine MAbs to human VH, determinants demonstrated diversity among antibodies to AM with qualitative and quantitative differences compared with antibodies to lipoarabinomannan. In summary, our study suggests that antibodies to AM are diverse and heterogeneous with respect to antigen recognition and VH, determinant expression, with human serum samples containing different subsets of antibodies to AM with the specificities of AM-binding murine MAbs. One MAb and a subset of human antibodies bind AM specifically, suggesting that this polysaccharide is antigenically distinct and is expressed in human infection.

Original languageEnglish (US)
Pages (from-to)88-94
Number of pages7
JournalClinical and Diagnostic Laboratory Immunology
Volume10
Issue number1
DOIs
StatePublished - Jan 2003
Externally publishedYes

Fingerprint

Antibody Diversity
Antibody Specificity
Mycobacterium tuberculosis
Antibodies
Monoclonal Antibodies
Polysaccharides
Arabinose
arabinomannan
Serum
Antigens

ASJC Scopus subject areas

  • Microbiology (medical)
  • Immunology and Allergy
  • Clinical Biochemistry
  • Immunology

Cite this

Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannan. / Navoa, Josephine Anne D; Laal, Suman; Pirofski, Liise-anne; McLean, Gary R.; Dai, Zhongdong; Robbins, John B.; Schneerson, Rachel; Casadevall, Arturo; Glatman-Freedman, Aharona.

In: Clinical and Diagnostic Laboratory Immunology, Vol. 10, No. 1, 01.2003, p. 88-94.

Research output: Contribution to journalArticle

Navoa, JAD, Laal, S, Pirofski, L, McLean, GR, Dai, Z, Robbins, JB, Schneerson, R, Casadevall, A & Glatman-Freedman, A 2003, 'Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannan', Clinical and Diagnostic Laboratory Immunology, vol. 10, no. 1, pp. 88-94. https://doi.org/10.1128/CDLI.10.1.88-94.2003
Navoa, Josephine Anne D ; Laal, Suman ; Pirofski, Liise-anne ; McLean, Gary R. ; Dai, Zhongdong ; Robbins, John B. ; Schneerson, Rachel ; Casadevall, Arturo ; Glatman-Freedman, Aharona. / Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannan. In: Clinical and Diagnostic Laboratory Immunology. 2003 ; Vol. 10, No. 1. pp. 88-94.
@article{fc82674dd59a4d11a2e437661c9cc0d2,
title = "Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannan",
abstract = "Arabinomannan (AM) is a polysaccharide antigen of the mycobacterial capsule. However, it is uncertain whether AM constitutes an immunologically distinct fraction of Mycobacterium tuberculosis. In this study, we analyzed the repertoire and specificity of antibodies to AM by using AM-binding murine monoclonal antibodies (MAbs) and human serum samples. Murine MAbs were found to be diverse in their specificity to AM and cross-reactivity with other arabinose-containing mycobacterial polysaccharides, with MAb 9d8 binding exclusively to AM. Human antibodies to AM were detected in serum samples from patients with pulmonary tuberculosis (TB), as well as in those from healthy, purified protein derivative-negative controls, with significantly higher titers among patients. The binding of human antibodies to AM was inhibited by MAb 9d8 in three patients with TB but not in controls. MAb 5c11, which recognizes other mycobacterial arabinose-containing carbohydrates in addition to AM, inhibited the binding of serum samples from 75{\%} of patients and 76{\%} of controls. Analysis of human antibodies with murine MAbs to human VH, determinants demonstrated diversity among antibodies to AM with qualitative and quantitative differences compared with antibodies to lipoarabinomannan. In summary, our study suggests that antibodies to AM are diverse and heterogeneous with respect to antigen recognition and VH, determinant expression, with human serum samples containing different subsets of antibodies to AM with the specificities of AM-binding murine MAbs. One MAb and a subset of human antibodies bind AM specifically, suggesting that this polysaccharide is antigenically distinct and is expressed in human infection.",
author = "Navoa, {Josephine Anne D} and Suman Laal and Liise-anne Pirofski and McLean, {Gary R.} and Zhongdong Dai and Robbins, {John B.} and Rachel Schneerson and Arturo Casadevall and Aharona Glatman-Freedman",
year = "2003",
month = "1",
doi = "10.1128/CDLI.10.1.88-94.2003",
language = "English (US)",
volume = "10",
pages = "88--94",
journal = "Clinical and Vaccine Immunology",
issn = "1556-6811",
publisher = "American Society for Microbiology",
number = "1",

}

TY - JOUR

T1 - Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannan

AU - Navoa, Josephine Anne D

AU - Laal, Suman

AU - Pirofski, Liise-anne

AU - McLean, Gary R.

AU - Dai, Zhongdong

AU - Robbins, John B.

AU - Schneerson, Rachel

AU - Casadevall, Arturo

AU - Glatman-Freedman, Aharona

PY - 2003/1

Y1 - 2003/1

N2 - Arabinomannan (AM) is a polysaccharide antigen of the mycobacterial capsule. However, it is uncertain whether AM constitutes an immunologically distinct fraction of Mycobacterium tuberculosis. In this study, we analyzed the repertoire and specificity of antibodies to AM by using AM-binding murine monoclonal antibodies (MAbs) and human serum samples. Murine MAbs were found to be diverse in their specificity to AM and cross-reactivity with other arabinose-containing mycobacterial polysaccharides, with MAb 9d8 binding exclusively to AM. Human antibodies to AM were detected in serum samples from patients with pulmonary tuberculosis (TB), as well as in those from healthy, purified protein derivative-negative controls, with significantly higher titers among patients. The binding of human antibodies to AM was inhibited by MAb 9d8 in three patients with TB but not in controls. MAb 5c11, which recognizes other mycobacterial arabinose-containing carbohydrates in addition to AM, inhibited the binding of serum samples from 75% of patients and 76% of controls. Analysis of human antibodies with murine MAbs to human VH, determinants demonstrated diversity among antibodies to AM with qualitative and quantitative differences compared with antibodies to lipoarabinomannan. In summary, our study suggests that antibodies to AM are diverse and heterogeneous with respect to antigen recognition and VH, determinant expression, with human serum samples containing different subsets of antibodies to AM with the specificities of AM-binding murine MAbs. One MAb and a subset of human antibodies bind AM specifically, suggesting that this polysaccharide is antigenically distinct and is expressed in human infection.

AB - Arabinomannan (AM) is a polysaccharide antigen of the mycobacterial capsule. However, it is uncertain whether AM constitutes an immunologically distinct fraction of Mycobacterium tuberculosis. In this study, we analyzed the repertoire and specificity of antibodies to AM by using AM-binding murine monoclonal antibodies (MAbs) and human serum samples. Murine MAbs were found to be diverse in their specificity to AM and cross-reactivity with other arabinose-containing mycobacterial polysaccharides, with MAb 9d8 binding exclusively to AM. Human antibodies to AM were detected in serum samples from patients with pulmonary tuberculosis (TB), as well as in those from healthy, purified protein derivative-negative controls, with significantly higher titers among patients. The binding of human antibodies to AM was inhibited by MAb 9d8 in three patients with TB but not in controls. MAb 5c11, which recognizes other mycobacterial arabinose-containing carbohydrates in addition to AM, inhibited the binding of serum samples from 75% of patients and 76% of controls. Analysis of human antibodies with murine MAbs to human VH, determinants demonstrated diversity among antibodies to AM with qualitative and quantitative differences compared with antibodies to lipoarabinomannan. In summary, our study suggests that antibodies to AM are diverse and heterogeneous with respect to antigen recognition and VH, determinant expression, with human serum samples containing different subsets of antibodies to AM with the specificities of AM-binding murine MAbs. One MAb and a subset of human antibodies bind AM specifically, suggesting that this polysaccharide is antigenically distinct and is expressed in human infection.

UR - http://www.scopus.com/inward/record.url?scp=0037246806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037246806&partnerID=8YFLogxK

U2 - 10.1128/CDLI.10.1.88-94.2003

DO - 10.1128/CDLI.10.1.88-94.2003

M3 - Article

C2 - 12522045

AN - SCOPUS:0037246806

VL - 10

SP - 88

EP - 94

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

SN - 1556-6811

IS - 1

ER -